Properties
Target: Proteinase K
Expression: Recombinant
Host: yeast
Recommended dilutions
Molecular biology applications: 50-100 µg / ml. The end-user must determine the optimal dilutions/concentrations.
Conjugation: in conjugated
Form: Liquid
Purity:
- ≥ 95% (SDS-PAGE)
- Free of DNase and RNase.
Storage
Store at -20 ° C for up to 1 year. Avoid repeated freeze/thaw cycles.
Enzyme commission number: 3.4.21.64
Molecular weight: 29 kDa
Buffer
PBS, 10 mM Tris-HCl, pH 7.5, containing 5 mM CaCl2 and 50% glycerin.
CAS number: 39450-01-6
Biological activity:
- ≥ 30 U / mg
- 1 Unit (U) is defined as the amount of proteinase K required to produce 1 µmol of folic-positive amino acids using haemoglobin as substrate, in 1 min at 37 ° C.
Concentration: 10 mg / ml
Instructions for use
- Effective pH range: 4-12.5
- Optimal pH range: 7.5-8.0
- Optimum reaction temperature: 50-55 ° C
Availability
Shipped within 5-10 business days.
Note
- This product is for research only.
- Not suitable for human, cosmetic, therapeutic or diagnostic consumption.
Bottom
Altering the function of a protein by changing its sequence allows natural proteins to become useful molecular tools. Current protein engineering methods are limited by the lack of high-throughput physical or computational tests that can accurately predict protein activity under conditions relevant to their end application. Here we describe a new synthetic biology approach to protein engineering that bypasses these limitations by combining high-throughput gene synthesis with design algorithms based on machine learning.
Results
We selected 24 amino acid substitutions to make in proteinase K from alignments of homologous sequences. We then designed and synthesized 59 specific proteinase K variants containing different combinations of the selected substitutions. All 59 variants were tested for the ability to hydrolyze a tetrapeptide substrate after the enzyme was first heated at 68 ° C for 5 minutes.
Sequence and activity data were analyzed using machine learning algorithms. This analysis was used to design a new set of variants predicted to have higher activity over the training set, which were then synthesized and tested. By running two cycles of variant design and machine learning analysis, we obtained 20-fold improved proteinase K variants while only testing a total of 95 variant enzymes.
Conclusion
The number of protein variants that must be tested for significant functional improvements determines the type of tests that can be performed. Protein engineers who want to modify the property of a protein to shrink tumours or catalyze chemical reactions under industrial conditions have so far been forced to accept high-throughput surrogate displays to measure the properties of proteins that they hope will correlate with functionalities that they intend to modify.
By reducing the number of variants that need to be tested to less than 100, machine learning algorithms allow more complex and expensive tests to be used, so that only those properties of proteins that are directly relevant to the intended application need to be measured. Protein design algorithms that only require testing of a small number of variants represent a significant step toward a resource-optimized generic protein engineering process.
